Tensions show no sign of easing ahead of President Xi Jinping’s upcoming meeting with Obama
Time has run out for Procter & Gamble's CEO as the company turns to a famed management star
Surprise, surprise: Target, Macy's, and 15 other retailers are suing Visa and MasterCard over card fees
The odd-job marketplace is getting traction with business customers
Net flow into debt hedge funds is the highest since 2007
Roel Vertegaal's PaperTab is like an iPad you can fold, spindle, or mutilate
Networks are staggering première dates to capture viewers and ad dollars
Jim Dean, the dean of UNC's Kenan-Flagler School, calls it quits for a more lofty title: provost
Rob Rhinehart is living on a substance he engineered to replace food, and he just raised more than $200,000 through crowdfunding to manufacture it
It falls from its current lofty peak, sure, but to where?
Do we assume that the company’s $36 stock price—the level it was at before Murdoch’s bid was made public—already contained a deal premium?
Curious to hear any and all thoughts.
UPDATE 7/20: Some thoughts on this here, with a major hat-tip to my colleagues Tom Lowry and Roben Farzad.
The media world continues to shapeshift as new forms arise and old assumptions erode. On this blog, Bloomberg Businessweek will provide sharp analysis and timely reports on the transformation of this constantly changing terrain.
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC Ad Choices
